Prof. Francesco Bertoni and his Colleague PD Anastasios Stathis of the Oncology Institute of Southern Switzerland (IOSI) has just been published a review article that summarizes the current knowledge on BET inhibitors in lymphomas. The article is based on the talk given at the 2018 “Inaugural AACR International Meeting Advances in Malignant Lymphoma”, a conference organized in cooperation with the International Conference on Malignant Lymphoma (ICML) and follows the works published by our groups studying the anti-tumor activity and the mechanism of actions of this class of epigenetic drugs.
Bertoni F, Stathis A.
BET inhibitors for lymphoid malignancies.
Current Opinion in Hematology 2019 May 20. doi: 10.1097/MOH.0000000000000519. [Epub ahead of print].